RIVERSIDE TAPPAHANNOCK HOSPITAL — History
CCN 490084 | 3-year financial timeline | COVID resilience: 50/100
🛡️ Public data only — no PHI permitted on this instance.
$59M
Latest Revenue (FY2022)
+6.5%
Revenue CAGR (3yr)
-3.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $52M | $51M | $59M | +16.0% | +6.5% |
| Operating Expenses | $54M | $54M | $61M | +12.9% | +6.0% |
| Operating Margin | -4.2% | -6.2% | -3.3% | +46.6% | +0.0% |
| Net Income | $-2M | $-3M | $-2M | +38.1% | +0.0% |
| Licensed Beds | 67 | 67 | 57 | -14.9% | -7.8% |
| Total Patient Days | 5,308 | 5,826 | 7,048 | +21.0% | +15.2% |
| Medicare Day % | 48% | 44% | 41% | -6.5% | -7.4% |
| Medicaid Day % | 3% | 3% | 13% | +311.5% | +104.2% |
COVID Impact & Recovery
Resilience Score: 50/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +13.4% ($52M → $59M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.5%
This Hospital
+7.6%
State Avg
Latest Margin
-3.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $63M | -2.8% |
| FY2024 (proj) | $66M | -2.4% |
| FY2025 (proj) | $70M | -1.9% |